We examined the effect of activated alveolar macrophages (AM) on airway responsiveness to muscarinic stimulation in 33 adult Sprague-Dawley rats. An isolated-perfused lung preparation was used to ensure precise and uniform delivery of cells into peripheral airways. The bronchoconstrictor response to acetylcholine (ACh) delivered into the pulmonary arterial circulation was augmented in 8 rats after infusion of 3 x 106 AM activated with 10-6 M f- met-leu-phe and 5 μg/ml of cytochalasin B. Lung resistance (RL) caused by 10-6 mol ACh increased 2.5-fold from 0.10 ± 0.004 cm H2O/ml/s before infusion of activated AM to 0.35 ± 0.05 cm H2O/ml/s after infusion of activated AM (N = 8; p < 0.05); the response to ACh was not augmented after infusion of nonactivated AM (N = 7) or vehicle control (N = 6). Baseline RL before ACh was similar in all three groups (p NS). Perfusion with activated AM also significantly increased the wet/dry (W/D) lung weight ratios (7.1 ± 0.5) compared with nonactivated AM (5.2 ± 0.1) or vehicle control (5.5 ± 0.3) (p < 0.05 versus either nonactivated AM or vehicle control). A63162, a 5-lipoxygenase inhibitor, but not indomethacin, a cyclooxygenase inhibitor, completely inhibited augmentation of bronchoconstrictor responses to ACh caused by activated AM and also completely attenuated the increase in W/D lung weight ratios. A highly significant (p < 0.01) correlation (R = 0.76) between W/D lung weight ratios and RL was observed after 10-6 mol ACh (the greatest dose of ACh administered). Baseline RL was equivalent for all groups before and after infusion of cells or vehicle. We demonstrate augmented muscarinic responsiveness in isolated-perfused lungs after exposure to activated AM. This augmentation occurs with the increase in the lung W/D ratio and is correlated with the magnitude of airway responsiveness. These effects of activated AM depend upon the elaboration of products of the 5- lipoxygenase pathway.
|Original language||English (US)|
|Number of pages||7|
|Journal||American Review of Respiratory Disease|
|Issue number||6 I|
|State||Published - Jan 1 1993|
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine